Phagenesis, a commercial-stage company with a first-of-its-kind neuromodulation system to treat patients experiencing difficulty swallowing post-stroke, welcomed the 2026 Guideline for the Early ...
The ASA now recognises pharyngeal electrical stimulation’s benefit in treating patients who experience difficulty swallowing following a stroke.